Symbols / ADTX Stock $0.20 +1.54% Aditxt, Inc.

Healthcare • Biotechnology • United States • NCM
ADTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Amro A. Albanna
Exch · Country NCM · United States
Market Cap 179.08K
Enterprise Value -1.67M
Income -43.10M
Sales 3.19K
FCF (ttm) -18.10M
Book/sh 13.63
Cash/sh 3.54
Employees —
Insider 10d —
IPO Jun 30, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.02
PEG —
P/S 56.05
P/B 0.01
P/C —
EV/EBITDA 0.09
EV/Sales -523.22
Quick Ratio 0.26
Current Ratio 0.31
Debt/Eq 76.04
LT Debt/Eq —
EPS (ttm) -9,230.64
EPS next Y -11.29
EPS Growth —
Revenue Growth -86.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-14
Earnings (prior) 2023-11-14
ROA -50.27%
ROE -6.99%
ROIC —
Gross Margin 8.39%
Oper. Margin -10,987.26%
Profit Margin 0.00%
Shs Outstand 904.47K
Shs Float 884.92K
Insider Own 2.16%
Instit Own 3.88%
Short Float 16.35%
Short Ratio 0.12
Short Interest 147.91K
52W High 2,495.04
vs 52W High -99.99%
52W Low 0.19
vs 52W Low 4.21%
Beta 1.40
Impl. Vol. —
Rel Volume 0.34
Avg Volume 1.42M
Volume 476.64K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.20
Price $0.20
Change 1.54%
About

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.20
Latest analyst target
3. DCF / Fair value
$-360.17
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.20
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-09-06 main HC Wainwright & Co. Buy → Buy $61
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-17 BRADY BRIAN MICHAEL Director — 1 $1.75 $2
2025-11-25 PANKOVCIN CORINNE D Officer — 1 $2.63 $3
2024-10-16 HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security — 25,534 $1.17 $29,875
2024-10-15 HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security — 15,636 $1.50 $23,454
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
-97.62%
0.13
-79.23%
0.65
-30.90%
0.93
Operating Revenue
0.00
-97.62%
0.13
-79.23%
0.65
-30.90%
0.93
Cost Of Revenue
0.00
-99.53%
0.63
-17.09%
0.76
-1.30%
0.77
Reconciled Cost Of Revenue
0.00
-99.53%
0.63
-17.09%
0.76
-1.30%
0.77
Gross Profit
0.00
+100.05%
-0.49
-341.96%
-0.11
-166.89%
0.17
Operating Expense
19.57
-28.50%
27.37
+5.47%
25.95
+3.38%
25.10
Research And Development
3.19
-70.66%
10.89
+53.88%
7.07
-2.67%
7.27
Selling General And Administration
16.38
-0.65%
16.48
-12.67%
18.88
+5.84%
17.84
Selling And Marketing Expense
0.40
+103.17%
0.20
-26.52%
0.27
-85.44%
1.85
General And Administrative Expense
15.97
-1.91%
16.29
-12.47%
18.61
+16.40%
15.99
Other Gand A
15.97
-1.91%
16.29
-12.47%
18.61
+16.40%
15.99
Total Expenses
19.57
-30.09%
28.00
+4.83%
26.71
+3.24%
25.87
Operating Income
-19.57
+29.76%
-27.86
-6.91%
-26.06
-4.52%
-24.94
Total Operating Income As Reported
-19.57
+29.76%
-27.86
-6.91%
-26.06
-2.29%
-25.48
EBITDA
-40.13
-48.40%
-27.04
-6.21%
-25.46
-2.54%
-24.83
Normalized EBITDA
-19.10
+30.44%
-27.45
-7.84%
-25.46
-4.83%
-24.28
Reconciled Depreciation
0.27
-55.84%
0.62
+13.76%
0.54
+1.23%
0.54
EBIT
-40.40
-46.08%
-27.66
-6.37%
-26.00
-2.51%
-25.36
Total Unusual Items
-21.03
-5173.24%
0.41
0.00
+100.00%
-0.54
Total Unusual Items Excluding Goodwill
-21.03
-5173.24%
0.41
0.00
+100.00%
-0.54
Special Income Charges
-23.85
0.00
0.00
+100.00%
-0.54
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
0.41
0.00
—
—
Restructuring And Mergern Acquisition
-0.33
0.00
—
—
Write Off
23.77
0.00
0.00
-100.00%
0.54
Net Income
-41.71
-21.10%
-34.45
-6.38%
-32.38
-17.11%
-27.65
Pretax Income
-42.79
-22.18%
-35.02
-8.12%
-32.39
-17.14%
-27.65
Net Non Operating Interest Income Expense
-2.19
+70.29%
-7.36
-15.40%
-6.38
-186.25%
-2.23
Interest Expense Non Operating
2.39
-67.57%
7.36
+15.24%
6.39
+179.51%
2.29
Net Interest Income
-2.19
+70.29%
-7.36
-15.40%
-6.38
-186.25%
-2.23
Interest Expense
2.39
-67.57%
7.36
+15.24%
6.39
+179.51%
2.29
Interest Income Non Operating
0.20
+13667.47%
0.00
-85.70%
0.01
-82.27%
0.06
Interest Income
0.20
+13667.47%
0.00
-85.70%
0.01
-82.27%
0.06
Other Income Expense
-21.03
-10316.46%
0.21
+298.03%
0.05
+110.66%
-0.48
Other Non Operating Income Expenses
—
-0.21
-503.52%
0.05
-12.29%
0.06
Gain On Sale Of Security
2.82
+580.70%
0.41
+701.56%
0.05
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-42.79
-22.18%
-35.02
-8.12%
-32.39
-17.14%
-27.65
Net Income From Continuing Operation Net Minority Interest
-41.71
-21.10%
-34.45
-6.38%
-32.38
-17.11%
-27.65
Net Income From Continuing And Discontinued Operation
-41.71
-21.10%
-34.45
-6.38%
-32.38
-17.11%
-27.65
Net Income Continuous Operations
-42.79
-22.18%
-35.02
-8.12%
-32.39
-17.14%
-27.65
Minority Interests
1.07
+87.05%
0.57
+5869.73%
0.01
0.00
Normalized Income
-20.69
+40.66%
-34.86
-7.66%
-32.38
-19.46%
-27.11
Net Income Common Stockholders
-43.10
-6.81%
-40.35
-23.40%
-32.70
-18.11%
-27.69
Otherunder Preferred Stock Dividend
1.39
-76.52%
5.91
+1746.69%
0.32
+749.21%
0.04
Diluted EPS
—
-282,192.29
-13.05%
-249,623.74
+90.98%
-2,768,755.30
Basic EPS
—
-282,192.29
-13.05%
-249,623.74
+90.98%
-2,768,755.30
Basic Average Shares
—
0.00
+9.16%
0.00
+1210.00%
0.00
Diluted Average Shares
—
0.00
+9.16%
0.00
+1210.00%
0.00
Diluted NI Availto Com Stockholders
-43.10
-6.81%
-40.35
-23.40%
-32.70
-18.11%
-27.69
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
32.14
-27.89%
44.58
+315.25%
10.74
—
Current Assets
2.00
-71.07%
6.91
+45.73%
4.74
—
Cash Cash Equivalents And Short Term Investments
0.83
+757.89%
0.10
-96.49%
2.77
—
Cash And Cash Equivalents
0.83
+757.89%
0.10
-96.49%
2.77
—
Cash Financial
0.83
+757.89%
0.10
-96.49%
2.77
—
Receivables
1.15
-80.31%
5.85
+1008.60%
0.53
—
Accounts Receivable
0.04
-89.36%
0.41
-22.66%
0.53
—
Gross Accounts Receivable
0.05
-88.38%
0.41
-25.30%
0.55
—
Allowance For Doubtful Accounts Receivable
-0.00
0.00
+100.00%
-0.02
—
Other Receivables
1.11
-79.64%
5.44
—
—
Inventory
0.01
-98.49%
0.75
-21.53%
0.95
—
Raw Materials
—
—
0.95
+92.06%
0.49
Prepaid Assets
0.00
-98.45%
0.22
-56.25%
0.50
—
Total Non Current Assets
30.14
-19.97%
37.67
+528.63%
5.99
—
Net PPE
2.77
-32.33%
4.10
-25.20%
5.48
—
Gross PPE
4.62
-13.71%
5.35
-15.02%
6.30
—
Accumulated Depreciation
-1.84
-47.30%
-1.25
-53.31%
-0.82
—
Properties
0.00
0.00
0.00
—
Buildings And Improvements
—
2.20
-30.38%
3.16
—
Machinery Furniture Equipment
0.44
+0.00%
0.44
+0.47%
0.43
—
Other Properties
4.06
-15.30%
4.79
+85.72%
2.58
—
Leases
0.12
+0.00%
0.12
+0.00%
0.12
—
Goodwill And Other Intangible Assets
0.01
-35.29%
0.01
-91.17%
0.11
—
Other Intangible Assets
0.01
-35.29%
0.01
-91.17%
0.11
—
Investments And Advances
27.28
+22.44%
22.28
0.00
—
Long Term Equity Investment
27.28
+22.44%
22.28
0.00
—
Non Current Deferred Assets
—
0.00
-100.00%
0.05
0.00
Non Current Prepaid Assets
0.09
-99.22%
11.28
+3074.24%
0.36
—
Other Non Current Assets
—
—
—
0.29
Total Liabilities Net Minority Interest
31.05
+8.84%
28.53
+416.04%
5.53
—
Current Liabilities
23.41
-9.59%
25.89
+610.53%
3.64
—
Payables And Accrued Expenses
15.46
+80.74%
8.55
+336.81%
1.96
—
Payables
12.44
+65.38%
7.52
—
—
Accounts Payable
10.19
+35.47%
7.52
—
—
Other Payable
2.25
—
—
—
Current Accrued Expenses
3.02
+192.82%
1.03
—
—
Current Debt And Capital Lease Obligation
6.48
-62.25%
17.18
+1047.65%
1.50
—
Current Debt
5.80
-64.14%
16.18
+3845.60%
0.41
—
Other Current Borrowings
0.15
+0.00%
0.15
-63.94%
0.41
-41.47%
0.70
Current Capital Lease Obligation
0.68
-31.66%
1.00
-7.98%
1.09
—
Current Deferred Liabilities
0.11
-33.12%
0.16
-15.89%
0.19
—
Other Current Liabilities
1.35
—
—
—
Total Non Current Liabilities Net Minority Interest
7.65
+189.43%
2.64
+40.13%
1.89
—
Long Term Debt And Capital Lease Obligation
0.44
-58.11%
1.04
-44.74%
1.89
—
Long Term Debt
—
—
—
0.11
Long Term Capital Lease Obligation
0.44
-58.11%
1.04
-44.74%
1.89
—
Other Non Current Liabilities
—
1.60
—
—
Preferred Securities Outside Stock Equity
7.20
—
—
—
Stockholders Equity
1.67
-89.57%
16.06
+208.40%
5.21
—
Common Stock Equity
1.67
-89.57%
16.06
+208.40%
5.21
—
Capital Stock
0.00
-19.44%
0.00
-66.67%
0.00
—
Common Stock
0.00
-90.91%
0.00
-89.81%
0.00
—
Preferred Stock
0.00
+12.00%
0.00
0.00
—
Share Issued
0.00
+9.16%
0.00
+1210.00%
0.00
—
Ordinary Shares Number
0.00
0.00
-100.00%
0.00
—
Treasury Shares Number
0.00
0.00
0.00
0.00
Additional Paid In Capital
169.97
+18.04%
144.00
+43.36%
100.45
—
Retained Earnings
-168.09
-31.59%
-127.74
-34.41%
-95.04
—
Gains Losses Not Affecting Retained Earnings
0.00
—
—
—
Treasury Stock
0.20
+0.00%
0.20
+0.00%
0.20
—
Minority Interest
-0.58
-5969.73%
-0.01
0.00
—
Other Equity Adjustments
—
—
—
—
Total Equity Gross Minority Interest
1.09
-93.20%
16.05
+208.22%
5.21
—
Total Capitalization
1.67
-89.57%
16.06
+208.40%
5.21
—
Working Capital
-21.41
-12.81%
-18.98
-1825.42%
1.10
—
Invested Capital
7.48
-76.81%
32.23
+473.91%
5.62
—
Total Debt
6.92
-62.01%
18.22
+438.70%
3.38
—
Net Debt
4.97
-69.11%
16.08
—
—
Capital Lease Obligations
1.12
-45.16%
2.04
-31.30%
2.97
—
Net Tangible Assets
1.67
-89.60%
16.05
+214.69%
5.10
—
Tangible Book Value
1.67
-89.60%
16.05
+214.69%
5.10
—
Current Notes Payable
5.65
-64.73%
16.03
0.00
—
Derivative Product Liabilities
0.01
0.00
—
—
Interest Payable
1.89
+387.38%
0.39
—
—
Investmentsin Subsidiariesat Cost
27.28
+22.44%
22.28
0.00
—
Non Current Note Receivables
0.00
—
—
—
Notes Receivable
—
—
0.00
-100.00%
0.50
Preferred Stock Equity
0.00
+12.00%
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-25.69
-53.25%
-16.76
+12.71%
-19.20
+14.24%
-22.39
Cash Flow From Continuing Operating Activities
-25.69
-53.25%
-16.76
+12.71%
-19.20
+14.24%
-22.39
Net Income From Continuing Operations
-42.79
-22.18%
-35.02
-8.12%
-32.39
-17.14%
-27.65
Depreciation Amortization Depletion
0.27
-55.84%
0.62
+13.76%
0.54
+1.23%
0.54
Depreciation
0.27
-56.14%
0.61
+41.12%
0.44
+1.41%
0.43
Amortization Cash Flow
0.00
+0.00%
0.00
-96.90%
0.11
+0.52%
0.11
Depreciation And Amortization
0.27
-55.84%
0.62
+13.76%
0.54
+1.23%
0.54
Amortization Of Intangibles
0.00
+0.00%
0.00
-96.90%
0.11
+0.52%
0.11
Other Non Cash Items
1.16
-72.51%
4.21
+96.56%
2.14
+39.79%
1.53
Stock Based Compensation
0.48
-92.84%
6.75
+381.14%
1.40
-55.23%
3.13
Asset Impairment Charge
24.18
0.00
0.00
-100.00%
0.54
Operating Gains Losses
-2.82
-585.66%
-0.41
—
0.01
Gain Loss On Investment Securities
-2.82
-580.70%
-0.41
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.00
0.00
-100.00%
0.01
Change In Working Capital
-6.17
-187.00%
7.09
-22.04%
9.10
+1944.03%
-0.49
Change In Receivables
0.04
-88.10%
0.36
+205.00%
0.12
+127.31%
-0.44
Changes In Account Receivables
0.04
-88.10%
0.36
+205.00%
0.12
+127.31%
-0.44
Change In Inventory
0.01
-99.25%
0.73
+258.89%
0.20
+144.93%
-0.46
Change In Prepaid Assets
-0.59
-352.59%
0.23
-55.96%
0.53
+4201.80%
-0.01
Change In Payables And Accrued Expense
-5.63
-210.56%
5.10
-23.34%
6.65
+1509.47%
0.41
Change In Other Current Liabilities
0.00
-100.00%
0.67
-58.31%
1.60
0.00
Investing Cash Flow
-2.44
+51.23%
-5.00
-34605.35%
-0.01
+94.04%
-0.24
Cash Flow From Continuing Investing Activities
-2.44
+51.23%
-5.00
-34605.35%
-0.01
+94.04%
-0.24
Net PPE Purchase And Sale
-0.01
0.00
+100.00%
-0.01
+96.08%
-0.37
Purchase Of PPE
-0.01
0.00
+100.00%
-0.01
+96.08%
-0.37
Capital Expenditure
-0.01
—
-0.01
+96.08%
-0.37
Net Investment Purchase And Sale
0.00
+100.00%
-5.00
0.00
—
Purchase Of Investment
0.00
+100.00%
-5.00
0.00
—
Net Other Investing Changes
-2.42
—
—
0.13
Financing Cash Flow
30.49
+35.53%
22.50
+35.97%
16.55
-5.61%
17.53
Cash Flow From Continuing Financing Activities
30.49
+35.53%
22.50
+35.97%
16.55
-5.61%
17.53
Net Issuance Payments Of Debt
-5.54
-295.90%
-1.40
-124.31%
5.75
+1496.70%
-0.41
Issuance Of Debt
1.87
-59.51%
4.62
-51.88%
9.59
+233.66%
2.88
Repayment Of Debt
-7.41
-23.14%
-6.01
-56.64%
-3.84
-16.83%
-3.29
Long Term Debt Issuance
—
—
—
2.88
Long Term Debt Payments
—
—
—
-3.69
Net Long Term Debt Issuance
—
—
—
-0.81
Short Term Debt Issuance
1.87
-59.51%
4.62
-51.88%
9.59
+233.66%
2.88
Short Term Debt Payments
-7.41
-23.14%
-6.01
-56.64%
-3.84
-16.83%
-3.29
Net Short Term Debt Issuance
-5.54
-295.90%
-1.40
-124.31%
5.75
+1496.70%
-0.41
Net Common Stock Issuance
44.13
+108.48%
21.17
+91.47%
11.05
-35.85%
17.23
Repurchase Of Capital Stock
-9.21
-222.82%
-2.85
-285087.10%
-0.00
+95.00%
-0.02
Proceeds From Stock Option Exercised
0.00
-100.00%
1.25
0.00
-100.00%
1.11
Net Other Financing Charges
1.11
-74.43%
4.34
+1760.24%
-0.26
+34.79%
-0.40
Changes In Cash
2.37
+221.44%
0.74
+127.55%
-2.67
+47.65%
-5.10
Beginning Cash Position
0.83
+757.89%
0.10
-96.49%
2.77
-64.83%
7.87
End Cash Position
3.20
+283.97%
0.83
+757.89%
0.10
-96.49%
2.77
Free Cash Flow
-25.70
-53.33%
-16.76
+12.78%
-19.22
+15.56%
-22.76
Interest Paid Supplemental Data
2.47
+99.54%
1.24
-59.76%
3.07
+307.76%
0.75
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
44.13
+108.48%
21.17
+91.47%
11.05
-35.85%
17.23
Issuance Of Capital Stock
44.13
+108.48%
21.17
+91.45%
11.06
-35.92%
17.25
Net Preferred Stock Issuance
-9.21
-222.82%
-2.85
0.00
0.00
Preferred Stock Issuance
—
0.00
-100.00%
0.00
-95.00%
0.02
Preferred Stock Payments
-9.21
-222.82%
-2.85
-285087.10%
-0.00
+95.00%
-0.02
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category